Navigation Links
Capital Edge Consulting expands CPSR Consulting Practice with addition of team member Michael Carter

Capital Edge Consulting, Inc., a nationwide consulting firm that specializes in helping federal government contractors solve complex business challenges, announces the addition of former Defense Contract Management Agency (DCMA) Contractor Purchasing System Review (CPSR) Procurement Analyst, Michael Carter, as the firm’s newest Senior Consultant and member of its CPSR Consulting Practice.

Mr. Carter brings extensive experience in the federal acquisition process and practical application of the acquisition regulations, contractor business systems compliance, DCMA processes and procedures, proposal analysis and evaluation, cost modeling and estimating, forward pricing rate agreements (FPRA), and training. Beyond his duties as a DCMA CPSR procurement analyst, he was also responsible for creating critical tools for DCMA, some of which were adopted by the entire CPSR Group for use during purchasing system reviews and another that was adopted by all Administrative Contracting Officers (ACO) to support their annual surveillance of contractor purchasing systems responsibilities.

Prior to joining DCMA’s CPSR Group, Mr. Carter also served as a DCMA Administrative Contracting Officer (ACO) and managed all activities related to Base Life Support on three US Military and US State Department installations in Iraq. He was responsible for approving or denying all work requests and managed all administrative aspects of prime contracts in excess of $3.1 billion. He assisted DCMA cost/price analysts in performing contractor proposal cost and price analysis, reviewing and finalizing forward pricing rate recommendations (FPRR), and performing Cost Accounting Standards compliance oversight on prime contractors.

“It is Mike’s critical and innovative thinking that makes him a great fit for Capital Edge Consulting,” says Chase Kunk, Capital Edge Consulting’s Vice President, Contracts and Procurement and CPSR Consulting Practice lead.“His vast knowledge of the DCMA CPSR process and deep exposure as a senior procurement analyst to a variety of contractor purchasing systems, procedures and practices is a true value-add to our clients as they monitor their own systems and prepare for their own DCMA reviews.”

Capital Edge Consulting’s CPSR Consulting Practice has seen significant growth over the last few years due to client demand. The Practice has been successfully supporting clients and their critical purchasing system needs as well as providing CPSR-focused thought leadership and training through Federal Publications Seminars and the Public Contracting Institute. Their “one size does not fit all” approach to purchasing system compliance has become their trademarked approach welcomed by clients in various industries’ with diverse business processes, products and services.

About Capital Edge Consulting
Capital Edge Consulting combines unique backgrounds and experience in consulting, public accounting, industry, and DCAA and DCMA to provide clients with unmatched government contracting expertise. This breadth of specialized experience enables them to provide the exact services and level of expertise federal government contractors need to succeed. Capital Edge Consulting provides custom-tailored consulting solutions to government contractors ranging in size from startup to Fortune 100 companies, in industries such as manufacturing, construction, transportation, nuclear energy, professional services, biotech/pharmaceuticals, defense and software.

To learn more about Capital Edge Consulting, visit

Follow Capital Edge Consulting for the latest updates and industry news:
LinkedIn| Facebook| Twitter

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
2. RXi Pharmaceuticals Announces Application for NASDAQ Capital Market Listing and Reverse Stock Split
3. Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
4. GW Pharmaceuticals to Present at the 2013 Aegis Capital Healthcare Conference
5. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
6. Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing
7. S&P Capital IQ to Share Its Views on the Biotech Bull Market During the Next "ETF Analyst Hour"
8. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
9. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
10. UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
11. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
Post Your Comments:
(Date:7/31/2020)... ... 2020 , ... Anomet Products has introduced new custom composite ... with CRM, neurostimulation, vascular, and related devices. , Anomet Medical Clad Wire ... and cost criteria; especially where solid wire is limited. Typical configurations for implantable ...
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode ... significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES . ... , Bode-CARES provides a turnkey solution that includes a comprehensive ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
Breaking Biology Technology:
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman Carl ... executive with expertise in clinical trial planning and feasibility, regulatory inspection readiness, and ... Throughout his career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, ...
(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... SAN ANTONIO (PRWEB) , ... July 16, 2020 ... ... PLOS ONE that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise ... (NICU) environment. The study reported that the Neoasis™ device attenuated the alarm sounds ...
Breaking Biology News(10 mins):